Paula S. Lee

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial

Michael Frumovitz, Marie Plante, Paula S. Lee et al. · The Lancet Oncology · 2018 · 335 citations

Cervical Cancer, Cancer Detection, Oncologic Imaging +7

Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer

Micael Lopez-Acevedo, Laura J. Havrilesky, Gloria Broadwater et al. · Gynecologic Oncology · 2013 · 113 citations

Palliative Care, Nursing, End-of-life Quality Indicators +12

Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study

Gottfried E. Konecny, Neil J. Finkler, Agustin A. García et al. · The Lancet Oncology · 2015 · 86 citations

Medicine, Second-line Dovitinib, Gynecology +6

Patient preferences in advanced or recurrent ovarian cancer

Laura J. Havrilesky, Angeles Alvarez Secord, Jessie Ehrisman et al. · Cancer · 2014 · 79 citations · Full text

Relationship between tamoxifen use and high risk endometrial cancer histologic types

Amy E. Bland, Brian Calingaert, Angeles Alvarez Secord et al. · Gynecologic Oncology · 2008 · 71 citations

Endocrine-related Cancer, Medicine, Pathology +7